TIDMSMIN
RNS Number : 8861O
Smiths Group PLC
22 May 2018
22 MAY 2018
SMITHS GROUP PLC ("Smiths")
DIRECTORATE CHANGES
As part of the Board's normal succession planning the Board is
pleased to announce a number of changes to the composition of the
Board and its Committees.
Smiths has appointed Olivier Bohuon and Dame Ann Dowling as
independent non-executive Directors with effect from 1 July and 19
September 2018 respectively. On joining the Board they will both
become members of the Nomination, Audit and Remuneration
Committees. Biographic details are set out below.
Following Bill Seeger's resumption of his non-executive Director
responsibilities on 1 January 2018, the Board has determined him to
be independent with immediate effect.
Bill Seeger will re-join the Nomination and Remuneration
Committees and has accepted the appointment of Remuneration
Committee chair designate with effect from 22 May 2018. In this
role he will lead the review of the Company's Directors'
Remuneration Policy which will be proposed to shareholders at the
2018 Annual General Meeting.
Having served for almost nine years on the Board, Anne Quinn,
current Remuneration Committee chair, will step down from the Board
on 1 July 2018. She will continue to oversee the review of the
Company's Directors' Remuneration Policy until she stands down, at
which point Bill Seeger will become chair of the Remuneration
Committee.
In view of his role during 2017 as Interim Chief Financial
Officer Bill Seeger will re-join the Audit Committee on 1 October
2018 or after the Full Year 2018 results have been published,
whichever is the sooner.
Smiths Chairman Sir George Buckley said:
"I am delighted that Olivier and Ann have agreed to join the
Smiths Board.
Olivier has had an extremely successful executive career in
MedTech and Ann is an internationally respected engineer and
technologist. They are both highly respected leaders in their
fields and I am confident they will further strengthen Board
discussions and bring invaluable insight as we continue to lead
Smiths on its growth journey.
I would like to thank Anne Quinn for the highly significant
contribution she has made to Smiths during her time on the Board
and particularly as chair of the Remuneration Committee. I am
grateful for her hard work and wise counsel over the years."
Biographic information:
Olivier Bohuon
Olivier held the role of Chief Executive Officer at Smith &
Nephew plc from April 2011 until his retirement from that role on 7
May 2018. Olivier holds a doctorate in Pharmacy from the University
of Paris and an MBA from HEC, Paris. He started his career in
Morocco with Roussel Uclaf S.A. and then, with the same company,
held a number of positions in the Middle East with increasing
levels of responsibility. He joined Abbott in Chicago as head of
their anti-infective franchise with Abbott International before
becoming Pharmaceutical General Manager in Spain. He subsequently
joined GlaxoSmithKline plc, rising to Senior Vice President &
Director for European Commercial Operations. He then re-joined
Abbott as President for Europe, became President of Abbott
International (all countries outside of the US), and then President
of their Pharmaceutical Division. He joined Smith & Nephew from
Pierre Fabre, where he was Chief Executive.
Olivier has extensive international healthcare leadership
experience within a number of significant pharmaceutical and
medical device companies. He is also a non-executive Director of
Virbac Group and Shire plc, where he is the Senior Independent
Director and a member of the Remuneration Committee and the
Nomination & Governance Committee.
Dame Ann Dowling
Dame Ann is a deputy vice-chancellor at the University of
Cambridge where she was appointed a professor of mechanical
engineering in the department of engineering in 1993. She was head
of the department of engineering at the University from 2009 to
2014. Her research is in fluid mechanics, acoustics and combustion,
and she has held visiting posts at MIT and at Caltech.
Dame Ann is an independent non-executive Director for BP plc
where she is also member of the safety, ethics and environment
assurance, nomination and chairman's committees. She also chairs
BP's Technical Advisory Council. Dame Ann is also a member of the
Prime Minister's Council for Science and Technology.
Dame Ann is a fellow of the Royal Society and the Royal Academy
of Engineering where she was elected President of the Royal Academy
of Engineering in September 2014 and in December 2015 was appointed
to the Order of Merit. Dame Ann is a foreign member of the US
National Academy of Engineering, the Chinese Academy of Engineering
and the French Academy of Sciences. She has honorary degrees from
fifteen universities, including the University of Oxford, Imperial
College London and the KTH Royal Institute of Technology,
Stockholm.
Dame Ann is an internationally respected leader in engineering
research and the practical application of new technology in
industry. Her contribution in these fields has been widely
recognised by universities and industry around the world.
There is no further information required to be disclosed
pursuant to LR 9.6.13.
Contact details:
Investor enquiries
Jemma Spalton, Smiths Group
+44 (0)20 7004 1637
+44 (0)78 6739 0350
jemma.spalton@smiths.com
Marion Le Bot, Smiths Group
+44 (0)20 7004 1672
+44 (0)75 8315 4386
marion.lebot@smiths.com
Media enquiries
Andrew Lorenz, FTI Consulting
+44 (0)203 727 1323
+44 (0)777 564 1807
smiths@fticonsulting.com
Deborah Scott, FTI Consulting
+44 (0)203 727 1459
+44 (0)797 953 7449
smiths@fticonsulting.com
Smiths Group is a global technology company listed on the London
Stock Exchange (SMIN) and operates a sponsored level one ADR
programme (SMGZY). A world leader in the practical application of
advanced technologies, Smiths Group delivers products and services
for the medical technology, security & defence, energy, space
& commercial aerospace, construction, transportation and
general industrial markets worldwide. Smiths Group employs c.22,000
colleagues in over 50 countries. For more information visit
www.smiths.com.
Legal Entity Identifier (LEI): 213800MJL6IPZS3ASA11
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
BOALLFFIEEIFFIT
(END) Dow Jones Newswires
May 22, 2018 11:07 ET (15:07 GMT)
Smiths (LSE:SMIN)
Historical Stock Chart
From Sep 2024 to Oct 2024
Smiths (LSE:SMIN)
Historical Stock Chart
From Oct 2023 to Oct 2024